Table 1.

Correlations, Scale Reliabilities, and Descriptive Results for Patients and Partners at Each Assessment

	CRSCa	PPSC	PPUC	CPDC	CNDC	IES	DAS7	Patients†			Partners†			t‡
								Alpha	Mean ± SD	Range	Alpha	Mean ± SD	Range
CRSCa
Baseline	.001	.15*	−.12	.22*	−.09	−.06	.19*	.71	4.18 ± .92	1.75–6.00	.70	3.26 ± .88	1.50–6.00	9.41***
3 months	− .04	.17	−.18	.17	−.07	−.01	.11	.79	4.11 ± .95	2.00–6.00	.67	3.28 ± .82	1.25–5.75	7.34***
6 months	− .04	.14	−.25*	.19	−.26*	−.19	.21*	.79	4.08 ± 1.01	2.00–6.00	.76	3.23 ± .92	1.00–6.00	5.82***
PPSCb
Baseline	.08	.34 **	−.28*	.41**	−.25**	−.04	.29**	.90	4.47 ± 1.05	1.67–6.00	.92	3.80 ± 1.06	1.33–6.00	7.23***
3 months	−.003	.30 **	−.16	.33**	−.27**	−.05	.34**	.91	4.34 ± 1.09	1.67–6.00	.90	3.79 ± .94	1.33–6.00	5.40***
6 months	−.02	.28 **	−.38**	.36**	−.47**	−.25*	.31**	.91	4.32 ± 1.11	1.83–6.00	.89	3.63 ± .96	1.33–6.00	5.68***
PPUCc
Baseline	−.07	−.28**	.30 **	−.28**	.32**	.02	−.25**	.82	1.68 ± .78	1.00–4.50	.86	1.80 ± .80	1.00–5.50	—
3 months	−.07	−.36**	.30 **	−.35**	.30**	.21*	−.38**	.78	1.60 ± .72	1.00–4.00	.82	1.84 ± .79	1.00–4.33	−2.95***
6 months	−.08	−.28**	.43 **	−.34**	.52**	.39**	−.32**	.82	1.72 ± .81	1.00–4.33	.83	1.96 ± .86	1.00–5.33	−2.52**
CPDCd
Baseline	.20**	.43**	−.29**	.49 **	−.27**	−.06	.39**	.90	3.97 ± 1.10	1.17–6.00	.90	3.78 ± 1.03	1.00–6.00	2.24*
3 months	.15	.54**	−.32**	.51 **	−.40**	−.13	.45**	.89	3.96 ± 1.06	1.50–6.00	.91	3.77 ± .98	1.33–6.00	2.64**
6 months	.06	.47**	−.48**	.52 **	−.53**	−.31**	.43**	.88	3.81 ± 1.04	1.17–6.00	.90	3.61 ± 1.01	1.00–6.00	2.29*
CNDCe
Baseline	−.11	−.31**	.31**	−.38**	.27 **	−.05	−.33**	—	2.13 ± 1.20	1.00–6.00	—	2.21 ± 1.12	1.00–6.00	—
3 months	−.10	−.35**	.31**	−.33**	.26 **	.15	−.37**	—	1.97 ± 1.00	1.00–5.00	—	2.19 ± 1.10	1.00–6.00	—
6 months	−.03	−.44**	.43**	−.45**	.56 **	.35**	−.41**	—	2.03 ± 1.11	1.00–5.00	—	2.18 ± 1.10	1.00–6.00	—
IESf
Baseline	.04	−.08	.19*	−.20**	.17*	.19 **	−.18*	.89	20.73 ± 14.36	0–55.00	.89	19.38 ± 13.71	0–66.00	—
3 months	.001	−.32**	.15	−.28**	.24*	.32 **	−.27**	.87	20.02 ± 13.12	0–58.00	.90	16.95 ± 12.87	0–54.00	—
6 months	−.10	−.19	.27*	−.33**	.47**	.38 **	−.27**	.90	19.23 ± 14.36	0–56.00	.91	18.71 ± 14.15	0–57.00	—
DAS7g
Baseline	.12	.38**	−.39**	.44**	−.37**	−.18*	.55 **	.87	25.66 ± 6.21	9.00–36.00	.89	24.80 ± 5.60	3.00–35.00	2.14*
3 months	.17	.40**	−.30**	.52**	−.35**	−.24*	.57 **	.84	24.92 ± 6.21	9.00–36.00	.90	24.88 ± 6.13	1.00–36.00	—
6 months	.07	.42**	−.43**	.50**	−.51**	−.43**	.54 **	.86	25.00 ± 6.13	7.00–36.00	.91	24.45 ± 6.49	2.00–36.00	—

Note. Patient correlations on lower diagonal, partner correlations on upper diagonal, and partial correlations are on the diagonal

^*p < .05.

^**p < .01.

^***p < .001.

^†Mean scores did not significantly differ for patients or partners over time.

^‡Paired t-tests examined differences in patient and partner scores at each assessment.

^aOwn Cancer-Related Stress Communication.

^bPerceived Partner Supportive Coping.

^cPerceived Partner Unsupportive Coping.

^dCommon Positive Dyadic Coping.

^eCommon Negative Dyadic Coping.

^fImpact of Events Scale Total Score.

^gShort Form 7-item Dyadic Adjustment Scale Total Score.